Product Image

Melatonin 20 mg

Pure Encapsulations
4.6
★ ★ ★ ★ ★
(58 ratings)
Melatonin 20 mg
Product Image
Score57
A transparent but excessive 20 mg melatonin capsule with weak value for routine use. Its fixed high dose is the central limitation.
How scoring works
Quantity:180 Capsule(s) • (180 servings)
Goals:
Sleep Support

Score 57

A transparent but excessive 20 mg melatonin capsule with weak value for routine use. Its fixed high dose is the central limitation.
How scoring works
$100.00($0.55 per serving)
Pure Formulas
$ 100.00
Vitacost
$ 100.00
Walmart
$ 100.00
Report prices

Analysis

Melatonin directly targets circadian timing and sleep onset, but 20 mg is an unusually aggressive amount. A larger dose does not necessarily improve sleep and can make next-day effects more likely.

The single active is easy to identify and there are no hidden blends. Standard capsule delivery offers no special support for maintaining sleep through the night.

The long bottle supply may appeal to established users, yet the cost and fixed megadose limit broad usefulness. Most people looking for routine support would have better control with a much lower-dose option.

Who is it for
  • Adults using a specifically directed high dose
  • Experienced melatonin users who prefer capsules
  • People who value a single-ingredient label
Best for
  • Professionally supervised high-dose use
  • Sleep-onset support rather than overnight maintenance
  • Users avoiding proprietary blends

Pros

  • Fully disclosed single active
  • Simple capsule format
  • Large bottle supply

Cons

  • 20 mg is excessive for many users
  • High cost for a basic formula
  • No sustained-release feature

Warnings

  • The 20 mg amount may cause pronounced next-day sleepiness, vivid dreams, or headache
  • Do not drive or perform hazardous tasks until effects are known
  • Discuss this megadose with a qualified professional before routine use

Nutrient quality

50 Lower impact

The melatonin megadose is poorly balanced for routine sleep support. Standard capsule delivery is straightforward but offers no sleep-maintenance advantage.

.

Ingredient transparency

81 Highest impact

Active amounts and the basic serving format are clear without hidden blends. Full directions, source purity, and inactive ingredients remain incomplete.

.

Customer satisfaction

59 Moderate impact

The supplied aggregate satisfaction signal is favorable and has some support from its response volume. Specific experience details are absent, so complaint patterns and purpose fit cannot be confirmed.

.

Value for money

31 Situational impact

The formula offers limited value beyond basic melatonin delivery. Dose or transparency weaknesses make better-balanced alternatives more appealing.

.
Report analysis

Goals

Sleep Support
Impact
Moderate effect
A+ Goal FitF Strength of SupportF CoverageB- Formula Quality
Melatonin · 20 mg

Melatonin directly signals the circadian system and is highly specific to sleep onset. The 20 mg amount is far beyond the low doses generally needed for that purpose.

Such a megadose raises the likelihood of next-day sleepiness, vivid dreams, headache, and disrupted timing rather than reliably better sleep. A standard capsule also provides no sustained-release feature for nighttime awakenings.

Study evidence
Melatonin Supportive 181 studies

Ingredients

IngredientAmount per serving
Melatonin
20 mg
Gluten Free Adults 18–50 Women
Report overview
Melatonin · 20 mg OverallScore34
F Active Ingredient Quality & BioavailabilityD- Dose, Safety & Label TransparencyF Value

The 20 mg amount is a megadose that raises the risk of next-day sleepiness. Capsule delivery offers standard absorption, but it does not provide sustained release. The high serving cost compounds the weak suitability of this megadose for routine sleep support.

Loading alternative details
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Meta-analysis: melatonin for the treatment of primary sleep disorders.
    Ferracioli-Oda E; Qawasmi A; Bloch MH · PloS one · 2013
    Meta-analysis1,683 participants19 studies pooledSleep Support forMelatonin
  2. Efficacy of melatonin with behavioural sleep-wake scheduling for delayed sleep-wake phase disorder: A double-blind, randomised clinical trial.
    Sletten TL; Magee M; Murray JM; Gordon CJ; Lovato N; Kennaway DJ; Gwini SM; Bartlett DJ; Lockley SW; Lack LC; Grunstein RR; Rajaratnam SMW; Delayed Sleep on Melatonin (DelSoM) Study Group · PLoS medicine · 2019
    Randomized trial116 participantsSleep Support forMelatonin
  3. Melatonin treatment for age-related insomnia.
    Zhdanova IV; Wurtman RJ; Regan MM; Taylor JA; Shi JP; Leclair OU · The Journal of clinical endocrinology and metabolism · 2001
    Randomized trial30 participantsSleep Support forMelatonin
  4. The Effectiveness of Melatonin for Sleep Disturbances in Parkinson' Disease: Systematic Review and Meta-Analysis.
    Yousef O; Abouelmagd ME; Khaddam H; Shbani A; Yousef R; Meshref M; Hanafi I · Journal of sleep research · 2026
    Meta-analysis409 participants8 studies pooledSleep Support forMelatonin
  5. Nightly treatment of primary insomnia with prolonged release melatonin for 6 months: a randomized placebo controlled trial on age and endogenous melatonin as predictors of efficacy and safety.
    Wade AG; Ford I; Crawford G; McConnachie A; Nir T; Laudon M; Zisapel N · BMC medicine · 2010
    Randomized trial791 participantsSleep Support forMelatonin
  6. Effects of exogenous melatonin on sleep: a meta-analysis.
    Brzezinski A; Vangel MG; Wurtman RJ; Norrie G; Zhdanova I; Ben-Shushan A; Ford I · Sleep medicine reviews · 2005
    Meta-analysis284 participants8 studies pooledSleep Support forMelatonin